छोड़कर सामग्री पर जाएँ

Cipla stock jumps to all-time high; Nuvama raises target price, sees 18% upside

Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.

Read More

​ Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts. Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.  Moneycontrol Latest News Read More  

Top 100 Best Sellers

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी
en_USEnglish hi_INहिन्दी